Hypertonic saline induces prostacyclin production via extracellular signal-regulated kinase (ERK) activation

Journal of Surgical Research

Volumn 83, Issue 2, 1999, Pages 141-146

  Arbabi, Saman ^a   Garcia, Iris ^a   Bauer, Gregory ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Dual specific mitogen activated protein kinase kinase; Endothelial cells; Endotoxin; Extracellular signal regulated kinase; Hypertonic saline; Mitogen activated protein kinase; PD 98059; Prostacyclin; Trauma

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 6 OXOPROSTAGLANDIN F1 ALPHA; HYPERTONIC SOLUTION; MITOGEN ACTIVATED PROTEIN KINASE; PROSTACYCLIN; SODIUM CHLORIDE;

ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REPERFUSION INJURY; RESUSCITATION; THROMBOCYTE AGGREGATION; UMBILICAL VEIN;

EID: 0033562093     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5583     Document Type: Article

References (29)

1. Coimbra R., Hoyt D. B., Junger W. G., Angle N., Wolf P., Loomis W., Evers M. F. Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J. Trauma. 42:1997;602.
2. Vassar M. J., Colleen A. P., Gannaway W. L., Holcroft J. W. 7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport. Arch. Surg. 126:1991;1065.
3. Mattox K. L., Maningas P. A., Moore E. E., Mateer J. R., Marx J. A., Aprahamian C., Burch J. M., Pepe P. E. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension: The U.S.A. multicenter trial. Ann. Surg. 213:1990;483.
4. Gemma M., Cozzi S., Piccoli S., Magrin S., De Vitis A., Cenzato M. Hypertonic saline fluid therapy following brain stem trauma. J. Neurosurg. Anesth. 8:1996;137.
5. Young E. F., Rosenwasser R. H., Vasthare U. S., Tuma R. F. Preservation of post-compression spinal cord function by infusion of hypertonic saline. J. Neurosurg. Anesth. 6:1994;122.
6. Rocha-e-Silva M., Negraes G. A., Soares A. M., Pontieri V., Loppnow L. Hypertonic resuscitation from severe hemorrhagic shock: Patterns of regional circulation. Circ. Shock. 19:1997;165.
7. 2. Intensive Care Med. 23:1997;146.
8. LI Z., Jiang Y., Ulevitch R., Han J. The primary structure of p38γ: A new member of p38 group of MAP kinase. Biochem. Biophys. Res. Commun. 228:1996;334.
9. Han J., Lee J.-D., Bibbs L., Ulevitch R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808.
10. Galcheva-Gargova Z., Derijard B., Wu I., Davis R. J. An osmosensing signal tranduction pathway in mammalian cells. Science. 265:1994;806.
11. Kumar S., McDonnell P. C., Gum R. J., Hand A. T., Lee J. C., Young P. R. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235:1997;533.
12. Senger R., Ahn N. G., Posada J., Munar E. S., Jensen A. M., Cooper J. A., Cobb M. H., Kreb E. G. Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J. Biol. Chem. 267:1992;14373.
13. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489.
14. Lazzar D. F., Wiese R. J., Brady M. J., Mastick C. C., Waters S. B., Yamauchi K., Pessin J. E., Cuatrecasas P., Saltiel A. R. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem. 270:1995;20801.
15. Magnuson D. K., Maier R. V., Pohlman T. H. Protein kinase C: A potential pathway of endothelial cell activation by endotoxin, tumor necrosis factor, and interleukin-1. Surgery. 106:1989;216.
16. Shapiro L., Dinarello. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. USA. 92:1995;12230.
17. Bhagyalakshmi A., Frangos J. A. Mechanism of shear-induced prostacyclin production in endothelial cells. Biochem. Biophys. Res. Commun. 158:1989;31.
18. Rowe G. G., McKenna D. H., Corliss R. J., Sialer S. Hemodynamic effects of hypertonic sodium chloride. J. Appl. Physiol. 32:1972;182.
19. Junger W. G., Coimbra R., Liu F. C., Herdon-Remelius C., Junger W., Junger H., Loomis W., Hoyt D. B., Altman A. Hypertonic saline resuscitation: A tool to modulate immune function in trauma patients? Shock. 8:1997;235.
20. 2. J. Surg. Res. 64:1996;203.
21. Junger W. G., Liu F. C., Loomis W. H., Hoyt D. B. Hypertonic saline enhances cellular immune function. Circ. Shock. 42:1994;190.
22. Bihari D. J., Tinker J. The therapeutic value of vasodilator prostaglandins in MOF associated with sepsis. Intensive Care Med. 15:1988;2.
23. Crutchley D. J., Conanan L. B., Que B. G. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor α and interleukin-1 in human monocytic THP-1 cells. J. Pharmacol. Exp. Ther. 271:1994;446.
24. Lefler A. M., Tabas J., Smith E. F. Salutary effects of prostacyclin in endotoxin shock. Pharmacology. 21:1980;206.
25. Jones G., Hurley J. V. The effects of prostacyclin on the adhesion of leukocytes to injured vascular endothelium. J. Pathol. 142:1984;51.
26. Rasmussen I., Arvidsson D., Zak A., Haglund U. Splanchnic and total body oxygen consumption in experimental fecal peritonitis in pigs: Effects of dextran and iloprost. Circ. Shock. 36:1992;299.
27. Johnson G. L., Vaillancourt R. R. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6:1994;230.
28. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179.
29. 2. FEBS Lett. 388:1996;180.